Stephanie Price
Stephanie is a journalist for Business of Cannabis, writing about science, research, policy and industry developments in cannabis, CBD and psychedelics. In 2013 Stephanie gained her BA in English and Media, focusing on journalism and propaganda, where her magazine 'Game Theory' focused on developments and disruptors over the coming decade including cannabis, psychedelics, blockchain/crypto and free speech. In 2015 Stephanie received her National Council for the Training of Journalists (NCTJ) diploma whilst working as a reporter in North Wales. Stephanie has a specialism in Medical Cannabis: The Health Effects of THC and CBD through the University of Colorado, and a certificate from the Medical Cannabis Clinicians Society on "Medical Cannabis Explained".
Stephanie Price · page 40
- Medical
Tikun receives licence to begin operations in Greek facility
The approval follows the successful completion of its 56,000m2 state-of-the-art production site in Corinth, Greece.
- Companies
Lyphe Group launches new medical cannabis clinic in Guernsey
The organisation is aiming to support the expanding patient community with the clinic’s opening.
- Medical
Tetra Bio-Pharma expands into Australia with new research subsidiary
The Canadian company is establishing research company Tetra Bio-Pharma Australia Pty Ltd.
- Cultivation
Trichome Pharma receives approval to cultivate cannabis for research
The Spanish pharmaceutical company has said the approval marks a significant milestone for the advancement of its pipeline of projects.
- Medical
Phase II trial for potential cannabis dementia treatment completed
MGC Pharma has carried out a clinical trial with its Cognican formula – an oral spray containing THC and CBD.
- Companies
Global medical cannabis market to reach £42.17bn by 2027
The global market is likely to rise at a CAGR of 26.6 per cent from 2019 to 2027.
- Companies
UK’s Lyphe Group secures £5m funding to expand into Europe
The funding round was led by Europe’s first cannabis and psychedelics fund, Leafy Tunnel.
- Medical
Patient’s cannabis case sets new precedent in UK court
A cannabis patient will not face a prison sentence after receiving legal support from Cancard.
- Medical
Panaxia to begin medical cannabis production in Malta
The company has announced that it has obtained a production license for medical cannabis products in the country.
- Companies
Kendra Mark appointed as director of product at Tenacious Labs
Mark has a passion for health and wellness.
- Uncategorized
Aurora stärkt deutsche Position mit EU-GMP-Anlage
Die hochmoderne Anlage bereitet sich nun auf die erste Lieferung von medizinischem Cannabis für deutsche Patienten vor.
